1. Home
  2. UTSI vs DARE Comparison

UTSI vs DARE Comparison

Compare UTSI & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

N/A

Current Price

$2.60

Market Cap

23.7M

ML Signal

N/A

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

HOLD

Current Price

$1.96

Market Cap

27.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTSI
DARE
Founded
1991
2015
Country
China
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
27.1M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
UTSI
DARE
Price
$2.60
$1.96
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
7.2K
84.9K
Earning Date
08-29-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,793,000.00
N/A
Revenue This Year
N/A
$3,843.33
Revenue Next Year
N/A
$8,700.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$1.61
52 Week High
$2.99
$9.19

Technical Indicators

Market Signals
Indicator
UTSI
DARE
Relative Strength Index (RSI) 56.24 49.28
Support Level $2.41 $1.85
Resistance Level $2.59 $2.02
Average True Range (ATR) 0.13 0.10
MACD 0.01 -0.01
Stochastic Oscillator 74.90 54.55

Price Performance

Historical Comparison
UTSI
DARE

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: